Patient Capital Management 13F, Q2 2024

Samantha McLemore · quarter ending 30 June 2024 · filed 14 August 2024 · SEC CIK 1854794

$1.88B
Filed US book
40
Positions
6.5%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q2 2024

The 25 largest of 40 positions. Weights are against the whole filed book. Changes are in shares held, against the Q1 2024 filing.

CompanyTickerValue% of bookvs Q1 2024
AMAZON COM INCAMZN$122.08M6.5%unchanged
ALPHABET INCGOOGL$109.52M5.8%unchanged
CITIGROUP INCC$105.54M5.6%-6% shares
EXPEDIA GROUP INCEXPE$90.21M4.8%unchanged
ENERGY TRANSFER L PET$86.95M4.6%-6% shares
META PLATFORMS INCMETA$80.64M4.3%-3% shares
GENERAL MTRS COGM$76.15M4.0%-9% shares
ONEMAIN HLDGS INCOMF$75.36M4.0%-17% shares
NVIDIA CORPORATIONNVDA$74.85M4.0%+900% shares
IAC INCPPLI$74.84M4.0%+11% shares
DELTA AIR LINES INC DELDAL$63.64M3.4%-30% shares
UBS GROUP AG$59.93M3.2%-13% shares
BIOGEN INCBIIB$59.64M3.2%+18% shares
CROCS INCCROX$55.39M2.9%-9% shares
NORWEGIAN CRUISE LINE HLDG L$53.31M2.8%+18% shares
ALIBABA GROUP HLDG LTDBABA$52.31M2.8%+15% shares
KOSMOS ENERGY LTDKOS$50.33M2.7%+13% shares
CANADA GOOSE HLDGS INCGOOS$50.22M2.7%-6% shares
UNITED AIRLS HLDGS INCUAL$48.34M2.6%-11% shares
SEADRILL 2021 LTD$46.74M2.5%unchanged
CVS HEALTH CORPCVS$43.69M2.3%+29% shares
ILLUMINA INCILMN$43.30M2.3%+69% shares
MATTEL INCMAT$41.72M2.2%-19% shares
TRAVEL PLUS LEISURE COTNL$40.48M2.1%-9% shares
COINBASE GLOBAL INCCOIN$39.81M2.1%-18% shares

What changed since Q1 2024

Against the Q1 2024 filing, Patient Capital Management opened 2 new positions, added to 10, trimmed 21, left 7 unchanged and exited 4. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • G2C$12.29M
  • SPY$401.7K

Exited

Added to

  • NVDA+900%$74.85M
  • PPLI+11%$74.84M
  • BIIB+18%$59.64M
  • NORWEGIAN CRUISE LINE HLDG L+18%$53.31M
  • BABA+15%$52.31M
  • KOS+13%$50.33M
  • CVS+29%$43.69M
  • ILMN+69%$43.30M

and 2 more

Trimmed

  • C-6%$105.54M
  • ET-6%$86.95M
  • META-3%$80.64M
  • GM-9%$76.15M
  • OMF-17%$75.36M
  • DAL-30%$63.64M
  • UBS GROUP AG-13%$59.93M
  • CROX-9%$55.39M

and 13 more

Other quarters

Source: SEC Form 13F-HR, accession 0001085146-24-003874, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.